Community oncology practices need to think outside of the box to keep up with competition and be successful, said Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health
Community oncology practices need to think outside of the box to keep up with competition and be successful, said Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health
Transcript
As Flatiron Health has grown, what have you learned about the practices you work with?
What we’ve learned is that as our network grows it actually supports everyone in the network. So when we get more people to use our software, that actually collectively helps everybody. That’s probably the number 1 message that we try to deliver to some of our core practices. It’s important that you’re actually out there helping facilitate the growth of our network because it’s only gonna help them.
Number 2 is that I believe that community oncologists need to think outside the box. They don’t want to get stagnant and stuck in ways and say to themselves well this is how we’ve always done things and this is how we’re gonna continue to do things because they’ll get stuck in what I would say is the MySpace era where they don’t think about the future and all of a sudden get toppled by a business that is thinking about the future. So, it’s sorta of making sure that you’re always innovating, always thinking about how to make my business better regardless of what happened in the past. I think that’s probably the biggest things that I would tell a practice is think outside the box and they should make sure that you’re thinking about how you can improve your business and how you can grow because staying steady is not gonna work long term in community oncology.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More